Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc. financial statements

Tevogen Bio Holdings Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2026

RevenueUSD 0EODHD
Net income−USD 26.28MEODHD
Cash and equivalentsUSD 552.37KEODHD
Total debtUSD 3.1MEODHD

Tevogen Bio Holdings Inc. financials on 6ix · Tevogen Bio Holdings Inc. on 6ix